Location: Rye, NY
CIK: 0001823138 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $497M (98.1% shares, 1.9% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | INDIVIOR PLC | 13,670,312 | $315M | 63.4% | $23.07 | $23.80 | — | ORD | G4766E116 |
| ROIV | ROIVANT SCIENCES LTD | 7,915,232 | $92.45M | 18.6% | $11.68 | $5.20 | +124.6% | SHS | G76279101 |
| ABUS | ARBUTUS BIOPHARMA CORP | 8,280,818 | $16.81M | 3.4% | $2.03 | $2.69 | -24.5% | COM | 03879J100 |
| IMVT | IMMUNOVANT INC | 427,256 | $16.4M | 3.3% | $38.39 | $22.60 | +69.8% | COM | 45258J102 |
| MMM | 3M CO | 130,000 | $12.17M | 2.4% | $93.62 * | $79.56 | -8.1% | COM | 88579Y101 |
| META | META PLATFORMS INC | 36,175 | $10.86M | 2.2% | $300.21 | $218.77 | +36.3% | CL A | 30303M102 |
| — | ESPERION THERAPEUTICS INC NE | 17,275,000 | $9.358M | 1.9% | $0.54 | $0.54 | — | NOTE 4.000%11/1 | 29664WAB1 |
| ESPR | ESPERION THERAPEUTICS INC NE | 7,672,170 | $7.519M | 1.5% | $0.98 | $1.43 | -31.3% | COM | 29664W105 |
| SONO | SONOS INC | 406,172 | $5.244M | 1.1% | $12.91 | $16.16 | -20.1% | COM | 83570H108 |
| OMEX | ODYSSEY MARINE EXPL INC | 1,371,874 | $5.131M | 1.0% | $3.74 | $5.35 | -30.0% | COM NEW | 676118201 |
| IMVT | IMMUNOVANT INC | 86,600 | $3.325M | 0.7% | $38.39 | $22.60 | +69.8% | Call | 45258J102 |
| HTZ | HERTZ GLOBAL HLDGS INC | 87,188 | $1.068M | 0.2% | $12.25 | $25.48 | -51.9% | COM NEW | 42806J700 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 164,807 | $875K | 0.2% | $5.31 | $11.10 | -52.2% | COM | 03969K108 |
| HTZWW | HERTZ GLOBAL HLDGS INC | 123,494 | $756K | 0.2% | $6.12 | $10.08 | — | *W EXP 06/30/205 | 42806J148 |